Holen Sie sich die Stockscreener-App
0.5122
2.81%
0.014
Schlusskurs vom Vortag:
$0.4982
Offen:
$0.5834
24-Stunden-Volumen:
42.58M
Relative Volume:
5.41
Marktkapitalisierung:
$3.54M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-12.05M
KGV:
-0.0815
EPS:
-6.2848
Netto-Cashflow:
$-10.14M
1W Leistung:
-4.64%
1M Leistung:
-38.50%
6M Leistung:
-66.08%
1J Leistung:
-82.09%
1-Tages-Spanne:
$0.48
$0.6387
1-Wochen-Bereich:
$0.4761
$0.6387
52-Wochen-Spanne:
$0.4711
$3.325
Autonomix Medical Inc Stock (AMIX) Company Profile
Firmenname
Autonomix Medical Inc
Sektor
Branche
Telefon
832-277-7816
Adresse
21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS
Vergleichen Sie AMIX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMIX
Autonomix Medical Inc
|
0.5122 | 3.44M | 0 | -12.05M | -10.14M | -6.2848 |
|
ABT
Abbott Laboratories
|
125.92 | 219.41B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.64 | 145.84B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.54 | 140.43B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
97.53 | 126.52B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 49.08B | 5.88B | 1.34B | 799.60M | 2.3489 |
Autonomix Medical Inc Aktie (AMIX) Neueste Nachrichten
Autonomix reports pain relief in pancreatic cancer patients across stages By Investing.com - Investing.com Nigeria
Why Autonomix Medical Inc. stock remains on buy listsMarket Risk Summary & Verified Trade Idea Suggestions - ulpravda.ru
Autonomix (AMIX) Stock: Clinical Subgroup Analysis Supports Potential Palliative Impact of RF Denervation - parameter.io
Autonomix Medical reports promising pain relief in pancreatic cancer - TipRanks
Autonomix Medical stock soars after pain relief data in pancreatic cancer - Investing.com Nigeria
Autonomix Medical, Inc. Announces New Clinical Data on Pancreatic Cancer Pain Relief - TradingView — Track All Markets
Autonomix Medical stock soars after pain relief data in pancreatic cancer By Investing.com - Investing.com Canada
Autonomix Showcases Compelling PoC Study Clinical Data Showing Rapid and Durable Pain Relief Across All Disease Stages of Pancreatic Cancer at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium - The Manila Times
Autonomix Medical Reports Positive Subgroup Analysis on Pain Relief in Pancreatic Cancer Patients Across All Disease Stages - Quiver Quantitative
New procedure helps ease severe pancreatic cancer pain fast - Stock Titan
Autonomix Medical announces pricing of $5M private placement - MSN
Can Autonomix Medical Inc. stock hit analyst price targets2025 Key Lessons & Proven Capital Preservation Tips - ulpravda.ru
How Autonomix Medical Inc. stock reacts to bond yieldsMarket Activity Summary & Weekly High Potential Stock Alerts - ulpravda.ru
Will Autonomix Medical Inc. stock outperform value stocks2025 Performance Recap & Expert Curated Trade Ideas - ulpravda.ru
Why Autonomix Medical Inc. stock remains resilientJuly 2025 Fed Impact & Community Trade Idea Sharing Platform - ulpravda.ru
Take Profit: Will Autonomix Medical Inc. stock attract ESG investorsMarket Trend Summary & Precise Swing Trade Alerts - ulpravda.ru
Growth Recap: How Autonomix Medical Inc stock reacts to bond yields2025 Volume Leaders & AI Powered Market Trend Analysis - moha.gov.vn
Was Autonomix Medical Inc (AMIX)’s session last reading good? - uspostnews.com
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Autonomix granted European patent on nerve-targeted therapies technology - MSN
Autonomix secures European patent for cardiac tissue treatment tech By Investing.com - Investing.com Nigeria
Silver Rises Sharply; Chicago PMI Surges In December - Benzinga
Autonomix Medical (AMIX) Stock: Skyrockets Following Major Patent Approval - parameter.io
Autonomix secures European patent for cardiac tissue treatment tech - Investing.com
Autonomix Medical, Inc. Granted European Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology - The Manila Times
Autonomix Medical, Inc. Strengthens Global IP Portfolio with New European Patent for Advanced Cardiac Treatment Technologies - Quiver Quantitative
Autonomix Medical, Inc. Granted European Patent on Platform - GlobeNewswire
Stocks Under $1: AMIX, TOON, SOAR, SJ, BNRG, PNPNF, PRSO – Double-Digit 2026 Watchlist - Barchart.com
Autonomix Medical (NASDAQ:AMIX) Trading 1.7% Higher – Still a Buy? - Defense World
Autonomix Medical, Inc. (NASDAQ: AMIX) Highlights Expanding IP Portfolio and Multi-Indication Platform Strategy in Virtual Investor CEO Connect Segment - 富途牛牛
Autonomix Medical, Inc. CEO Discusses Key Strategic Priorities in Recent Virtual Investor Connect Segment - Quiver Quantitative
Autonomix Medical, Inc. (NASDAQ: AMIX) Highlights Expanding - GlobeNewswire
Can Autonomix Medical Inc stock resist sector downturnsTrade Analysis Report & AI Driven Price Predictions - moha.gov.vn
Portfolio Shifts: Why Autonomix Medical Inc stock appeals to analysts2025 Key Highlights & Free Community Consensus Stock Picks - moha.gov.vn
Autonomix to present pancreatic cancer pain treatment data at ASCO By Investing.com - Investing.com Australia
Is Autonomix Medical Inc. stock cheap at current valuationMarket Movers & Risk Managed Investment Entry Signals - DonanımHaber
How Autonomix Medical Inc. stock trades during market volatilityJuly 2025 PreEarnings & Consistent Profit Alerts - Улправда
Autonomix to present pancreatic cancer pain treatment data at ASCO - Investing.com
Autonomix Medical, Inc. Announces Abstract Selected for Poster Presentation at the 2026 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium - The Manila Times
Autonomix Medical, Inc. to Present Research on Pain Mitigation in Pancreatic Adenocarcinoma at 2026 ASCO Gastrointestinal Cancers Symposium - Quiver Quantitative
Autonomix Medical, Inc. Announces Abstract Selected for - GlobeNewswire
Published on: 2025-12-18 16:56:13 - Улправда
Head to Head Analysis: Autonomix Medical (NASDAQ:AMIX) & Nuwellis (NASDAQ:NUWE) - Defense World
[424B3] Autonomix Medical, Inc. Prospectus Filed Pursuant to Rule 424(b)(3) - Stock Titan
Critical Review: Autonomix Medical (NASDAQ:AMIX) versus Atossa Genetics (NASDAQ:ATOS) - Defense World
Can Autonomix Medical Inc. stock resist market sell offsQuarterly Growth Report & AI Forecast for Swing Trade Picks - Newser
Retail Surge: Why Autonomix Medical Inc stock could rally in 2025Insider Selling & Weekly Watchlist for Hot Stocks - BỘ NỘI VỤ
Why Autonomix Medical Inc. stock could rally in 2025Swing Trade & Real-Time Volume Triggers - Newser
What momentum indicators show for Autonomix Medical Inc. stock2025 Market Overview & Low Risk Growth Stock Ideas - Newser
Published on: 2025-12-02 08:15:20 - BỘ NỘI VỤ
Finanzdaten der Autonomix Medical Inc-Aktie (AMIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.31%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):